Question 1

Does Goldman Sachs own ENLV stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Goldman Sachs holds 89,417 shares of ENLV (Enlivex Therapeutics), worth $49,170.

Question 2

How many shares of ENLV does Goldman Sachs own?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs holds 89,417 shares of ENLV (Enlivex Therapeutics).

Question 3

What is Goldman Sachs' ENLV position worth?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs' ENLV position is worth $49,170.

Question 4

Is Goldman Sachs buying or selling ENLV?

Accepted Answer

In Q2 2026, Goldman Sachs reduced its ENLV position by 12,676 shares (-12.4%).

Question 5

When did Goldman Sachs first buy ENLV?

Accepted Answer

Goldman Sachs first reported ENLV in its Q3 2022 13F and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	89,417	-12.4%	$49,170	0.0%	$131.98	0
2026-Q1	New	102,093	-	$94,957	0.0%	$223.22	33
2024-Q4	Exited	0	-100.0%	$0	0.0%	$280.80	0
2024-Q3	Increased	13,935	+21.9%	$23,411	0.0%	$403.20	16

ENLVShowing 4 of 10 quarters

ENLV
Showing 4 of 10 quarters